Francisco Perez-Vizcaino & Gema Mondejar-Parreño. (2022). Antiproliferative miR-212-5p: Promising RNA therapy for pulmonary hypertension. Elsevier.
Chicago Style (17th ed.) CitationFrancisco Perez-Vizcaino and Gema Mondejar-Parreño. Antiproliferative MiR-212-5p: Promising RNA Therapy for Pulmonary Hypertension. Elsevier, 2022.
MLA (9th ed.) CitationFrancisco Perez-Vizcaino and Gema Mondejar-Parreño. Antiproliferative MiR-212-5p: Promising RNA Therapy for Pulmonary Hypertension. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.